A common blood pressure drug belonging to the class angiotensin-converting enzyme inhibitors (ACEI) can increase the risk of lung cancer. The risk increases after 5 years of use of ACEIs, which peaks after 10 years.
from Medindia Health News https://ift.tt/2ziJhjj
No comments:
Post a Comment